Protea Biosciences Cash Flow - Annual (OTCMKTS:PRGBQ)

Add to My Stocks
$0.01 $0 (0%) PRGBQ stock closing price Sep 20, 2018 (Closing)

The financial analysis of PRGBQ requires an investor to check the cash flows for Protea Biosciences. Financials statements like the Protea Biosciences income statement and Protea Biosciences balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Protea Biosciences had cash and cash equivalents of $- at beginning of the year and $- at year end for 2016. Protea Biosciences cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Protea Biosciences saw a inflow of $1.47M from investing activities for 2016.

View details of Protea Biosciences cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----1M1.27M
Net Increase (Decrease) in Assets Liabilities--1.66M-1.74M-0.42M1.5M
Cash From (used in) Discontinued Operations------
Other Adjustments Net10.28M3.18M1.64M2.09M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M--0.4M-0.47M-0.4M-1.24M
Acquisition Disposition of Subsidiaires---0.06M---
Increase (Decrease) in Investments1.5M-----
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.1M1.68M3.72M9.35M5.73M2.28M
Issuance (Repayment) of Debt Securities-1.33M-0.11M-1.42M-0.85M-0.27M-0.4M
Increase (Decrease) in Bank & Other Borrowings3.4M2.98M4.16M3.23M2.96M7.4M
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-0.35M-0.3M----
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---0.02M--0.02M-
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year--1.08M---
Cash & Equivalents at Year End---1.08M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our MEDPACE HLDGS financial analysis

Protea Biosciences stock price history provides insight into historical stock price fluctuations, and Protea Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Protea Biosciences saw a negative change in Net Change in Cash and Cash Equivalents of $- in 2016. Apart from the Protea Biosciences stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Protea Biosciences reported a negative operating cash flow of $-4.22M for 2016 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $1.47M for PRGBQ in last 2016 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Protea Biosciences earned $2.82M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Protea Biosciences Cash Flow

Annual Cash Flow Statements For Protea Biosciences Group Inc Peers

Aspyra cash flow, Medical Connections cash flow, MEDPACE HLDGS cash flow